Noble Life Sciences Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Noble Life Sciences General Information

Description

Provider of GLP and non-GLP services intended to accelerate the development of drugs, vaccines, and medical devices. The company's services offer experimental design and testing, early safety assessments, toxicology, and vivarium services, enabling physicians to do safety and efficacy testing of any drug candidate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1500 Fannie Dorsey Road
  • Sykesville, MD
  • United States
+1 (800) 000-0000
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1500 Fannie Dorsey Road
  • Sykesville, MD
  • United States
+1 (800) 000-0000

Noble Life Sciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noble Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-May-2021 00000 Completed Generating Revenue
5. Later Stage VC 01-Dec-2020 00000 00000 Completed Generating Revenue
4. Grant 04-Dec-2013 00000 00000 Completed Generating Revenue
3. Debt - General 11-Jun-2013 00000 Completed Generating Revenue
2. Seed Round 30-Mar-2012 $235K $235K Completed Generating Revenue
1. Grant 11-Feb-2011 $250K Completed Generating Revenue
To view Noble Life Sciences’s complete valuation and funding history, request access »

Noble Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of GLP and non-GLP services intended to accelerate the development of drugs, vaccines, and medical devices. The
Biotechnology
Sykesville, MD
36 As of 2024
00000
00000000000 00000

000000

is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
0000 000000000
Wilmington, MA
00000 As of 0000
00.000
000000000 - 00.000

0000 0

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000 000000000
Lexington, KY
00 As of 0000
00.000
000.00 0000-00-00
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noble Life Sciences Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charles River Laboratories International Formerly PE-Backed Wilmington, MA 00000 00.000 000000000 - 00.000
Hera BioLabs Venture Capital-Backed Lexington, KY 00 00.000 00000000000 00.000
Melior Discovery Venture Capital-Backed Exton, PA 00 00.000 000000000 - 00.000
Rho Corporation Chapel Hill, NC 000 0000000000
Covance Formerly PE-Backed Princeton, NJ 00000 00000 000000000 00
You’re viewing 5 of 37 competitors. Get the full list »

Noble Life Sciences Executive Team (11)

Name Title Board Seat
Kenneth Carter Ph.D Co-Founder, Co-Chief Executive Office & Chairman
Alain Cappeluti Co-Founder & President
Robyn Shaw Chief Operating Officer
Stephen Horrigan Ph.D Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 4 of 11 executive team members. Get the full list »

Noble Life Sciences Board Members (3)

Name Representing Role Since
Kenneth Carter Ph.D Noble Life Sciences Co-Founder, Co-Chief Executive Office & Chairman 000 0000
Srujana Cherukuri Ph.D Noble BioVentures Board Member 000 0000
Stephen Horrigan Ph.D Noble Life Sciences Co-Founder, Chief Scientific Officer & Board Member 000 0000
To view Noble Life Sciences’s complete board members history, request access »

Noble Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noble Life Sciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Maryland Biotechnology Center Government 000 0000 000000 0
Montgomery County Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
BroadOak Capital Partners Growth/Expansion Minority 000 0000 000000 0
To view Noble Life Sciences’s complete investors history, request access »

Noble Life Sciences Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Spring Valley Laboratories 03-Dec-2014 0000000000 Other Healthcare Services 00000 000
SynAm Vaccine 16-Apr-2013 Grant 0000 Drug Discovery
To view Noble Life Sciences’s complete investments and acquisitions history, request access »

Noble Life Sciences FAQs

  • When was Noble Life Sciences founded?

    Noble Life Sciences was founded in 2010.

  • Who is the founder of Noble Life Sciences?

    Kenneth Carter Ph.D, Alain Cappeluti, and Stephen Horrigan Ph.D are the founders of Noble Life Sciences.

  • Who is the CEO of Noble Life Sciences?

    Kenneth Carter Ph.D is the CEO of Noble Life Sciences.

  • Where is Noble Life Sciences headquartered?

    Noble Life Sciences is headquartered in Sykesville, MD.

  • What is the size of Noble Life Sciences?

    Noble Life Sciences has 36 total employees.

  • What industry is Noble Life Sciences in?

    Noble Life Sciences’s primary industry is Biotechnology.

  • Is Noble Life Sciences a private or public company?

    Noble Life Sciences is a Private company.

  • What is Noble Life Sciences’s current revenue?

    The current revenue for Noble Life Sciences is 000000.

  • How much funding has Noble Life Sciences raised over time?

    Noble Life Sciences has raised $335K.

  • Who are Noble Life Sciences’s investors?

    Maryland Biotechnology Center, Montgomery County, TEDCO, and BroadOak Capital Partners have invested in Noble Life Sciences.

  • Who are Noble Life Sciences’s competitors?

    Charles River Laboratories International, Hera BioLabs, Melior Discovery, Rho, and Covance are some of the 37 competitors of Noble Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »